These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23028112)

  • 21. Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells.
    Hackstein H; Hagel N; Knoche A; Kranz S; Lohmeyer J; von Wulffen W; Kershaw O; Gruber AD; Bein G; Baal N
    PLoS One; 2012; 7(8):e43320. PubMed ID: 22927956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
    Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
    J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmunity. IRF5 mediates joint inflammation.
    Duarte JH
    Nat Rev Rheumatol; 2015 Oct; 11(10):562. PubMed ID: 26369611
    [No Abstract]   [Full Text] [Related]  

  • 25. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.
    Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B
    Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.
    Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 7 mediates early innate immune responses to malaria.
    Baccarella A; Fontana MF; Chen EC; Kim CC
    Infect Immun; 2013 Dec; 81(12):4431-42. PubMed ID: 24042114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of interleukin-1, interleukin-2, alpha-interferon, and gamma-interferon on human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    Trans Assoc Am Physicians; 1984; 97():182-9. PubMed ID: 6442950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of natural killer cytotoxicity by alpha or gamma natural and recombinant interferons and interferon inducers. Effect of monocytes.
    Platsoucas CD; Fernandes G; Good RA; Gupta S
    Int Arch Allergy Appl Immunol; 1986; 79(1):1-7. PubMed ID: 3079737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting Edge: Induction of Inflammatory Disease by Adoptive Transfer of an Atypical NK Cell Subset.
    Voynova E; Qi CF; Scott B; Bolland S
    J Immunol; 2015 Aug; 195(3):806-9. PubMed ID: 26109646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells.
    Giltiay NV; Chappell CP; Sun X; Kolhatkar N; Teal TH; Wiedeman AE; Kim J; Tanaka L; Buechler MB; Hamerman JA; Imanishi-Kari T; Clark EA; Elkon KB
    J Exp Med; 2013 Nov; 210(12):2773-89. PubMed ID: 24145511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
    Schmidt KN; Leung B; Kwong M; Zarember KA; Satyal S; Navas TA; Wang F; Godowski PJ
    J Immunol; 2004 Jan; 172(1):138-43. PubMed ID: 14688319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice.
    Desnues B; Macedo AB; Roussel-Queval A; Bonnardel J; Henri S; Demaria O; Alexopoulou L
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1497-502. PubMed ID: 24474776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: Type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling.
    Buechler MB; Teal TH; Elkon KB; Hamerman JA
    J Immunol; 2013 Feb; 190(3):886-91. PubMed ID: 23303674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.
    Ramanujam M; Kahn P; Huang W; Tao H; Madaio MP; Factor SM; Davidson A
    Arthritis Rheum; 2009 Apr; 60(4):1096-101. PubMed ID: 19333924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells.
    Yi S; Feng X; Hawthorne WJ; Patel AT; Walters SN; O'Connell PJ
    Transplantation; 2002 Feb; 73(3):437-46. PubMed ID: 11884942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation.
    Wu YY; Kumar R; Iida R; Bagavant H; Alarcón-Riquelme ME
    PLoS One; 2016; 11(5):e0156302. PubMed ID: 27228057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
    Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
    Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7.
    Wang Y; Yan S; Yang B; Wang Y; Zhou H; Lian Q; Sun B
    FEBS Lett; 2015 May; 589(12):1322-30. PubMed ID: 25907537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon and host defense systems.
    Johnson HM
    Adv Exp Med Biol; 1983; 162():105-19. PubMed ID: 6191529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.